Automated Retinal Image Analysis for Zone 1 Boundary

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnosis of retinopathy of prematurity (ROP) is a manual process prone to subjective judgments, leading to inaccurate determination of zone 1 boundary and less than optimal treatment selections.

Innovation Solution

An automated system and method using a graphical user interface (GUI) for analyzing retinal images to determine vascular distributions and assign zone 1 boundaries, potentially incorporating machine learning and artificial intelligence for consistent and accurate diagnosis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual diagnosis process is used, then ease of operation is maintained, but measurement precision deteriorates due to subjective judgments in determining zone 1 boundary

Engineering Contradiction:
Improvezone 1 boundary determination accuracyVSAvoidautomated system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the manual mechanical assessment process with an automated image analysis system that uses computer algorithms to objectively determine the zone 1 boundary. The system processes retinal images through defined computational steps, eliminating subjective human judgment while maintaining operational simplicity through a user-friendly interface.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If automated system is implemented, then measurement precision improves through objective analysis, but device complexity increases

Engineering Contradiction:
Improvezone 1 boundary determination accuracyVSAvoidsystem operation simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The automated system performs self-analysis by automatically processing retinal images and determining zone 1 boundaries without requiring manual intervention. The system independently executes the diagnostic algorithm, generates measurements, and presents results, thereby maintaining ease of operation while achieving high measurement precision through objective computational analysis.

Inventive Principle:
Principle #25Self-service

3Reliability

If manual designation of zone 1 boundary is performed, then device complexity remains low, but reliability deteriorates due to considerable variation in manual designation

Engineering Contradiction:
Improvediagnosis consistencyVSAvoidautomated analysis system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent transforms the subjective manual parameter estimation into an objective computational process by changing the methodology from human visual assessment to algorithmic image analysis. The system applies consistent mathematical criteria and threshold values to determine the zone 1 boundary, eliminating inter-observer variability and ensuring reliable, reproducible results across different users and cases.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9622657B2Automated system for measurement of zone 1 in assessment of severity of retinopathy of prematurity
Publication Date: 2017.04.18 NEOLIGHT LLC
  • US9622657B2 patent drawing
  • US9622657B2 patent drawing
  • US9622657B2 patent drawing

AI summary

An automated method for diagnosing and evaluating severity of retinopathy of prematurity in a retina of a patient is provided that is superior to conventional techniques. A graphical user interface (GUI) is provided for receiving biographical information for the patient creating a patient record in a database via the GUI. A photograph of the retina of the patient is collected and placed in the patient record via the GUI. The photograph is then analyzed to determine vascular distributions within the retina. A zone 1 boundary is assigned to the retina based on a set of threshold levels with respect to the determined vascular distributions. A system for performing the automated method is also provided.